阿奇霉素序贯用于小儿支原体肺炎治疗疗效—成本分析
2015-10-21李永莉
李永莉
摘要: 目的: 总结性探讨分析小儿支原体肺炎采取阿奇霉素序贯疗法的治疗疗效和成本。方法: 将200例小儿支原体肺炎患者分为两组,分别为观察组和对照组,其中观察组的患者采取序贯疗法,对照组的患者采取传统疗法,比较分析两组患者的治疗费用、住院天数、治疗疗效的差异。结果: 观察组和对照组患者在胸片正常时间、体温恢复时间、咳嗽缓解时间的比较均无统计学差异,观察组较对照组的住院天数少,治疗费用低,且两方面的差异显著,均具有统计学意义。结论: 阿奇霉素序贯疗法用于治疗小儿支原体肺炎能够提高治疗效果,能够减少治疗成本,应在临床工作中加大使用范围。
关键词: 阿奇霉素;序贯治疗;小儿支原体肺炎
Abstract:Objective To investigate summary analysis of mycoplasma pneumonia in children taking azithromycin sequential therapy treatment efficacy and cost. Methods 200 patients were divided into two groups mycoplasma pneumonia in children, respectively, the observation group and the control group, patients in the observation group to take sequential therapy, patients in the control group take traditional therapies, comparative analysis of the cost of treatment of two groups of patients, length of hospital stay differences in treatment efficacy. Results observation group and the control group of patients normal chest radiograph time, temperature recovery time, relieve cough were no significant differences in time, the observation group than the number of hospital days in the control group, low cost of treatment, and significant differences between the two aspects are statistically significant. Conclusion azithromycin sequential therapy for the treatment of mycoplasma pneumonia in children can improve the therapeutic effect, can reduce the cost of treatment, should increase in the use of clinical work.
Keywords:azithromycin; sequential therapy; Mycoplasma Pneumonia
小儿支原体肺炎的感染菌为支原体,发病群体大多为儿童和青少年,发病率呈上升状态,严重威胁儿童的身体健康。小儿支原体肺炎属于急性呼吸道感染性肺炎,可引起多种并发症,比如说上呼吸道感染、气管支气管炎等[1]。阿奇霉素是一种抗生素,属于广谱抗菌素,是由红霉素的结构基础上加以修饰而成,目前主要治疗传播性疾病,这些疾病多为皮肤软组织感染、衣原体、呼吸道感染形成的[2]。
1 资料与方法
1.1一般资料
研究对象为2014年10月到2015年10月在我院进行救治的200例小儿支原体肺炎患者,两组患者各占全部患者的二分之一,其中观察组患者的男女比例为43:57,年龄为2个月到5岁,病程5~14天,平均年龄为2.4岁,平……
